Back to McKinsey Chart of the Day

Hope on the horizon for people with serious, often rare, diseases

Cell and gene therapies offer treatment, and sometimes cures, for patients with serious, often rare, and never-before-addressed diseases. And many more have become available in recent years—more than 75 launched worldwide in 2019, and 96 new ones were on track for the end of 2020.

The number of cell and gene therapies launched globally has steadily increased.
We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at:

To read the article, see “A call to action: Opportunities and challenges for CGTs in Europe,” January 19, 2021.